GO:1905399 regulation of activated CD4-positive, alpha-beta T cell apoptotic process: Immune Homeostasis, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1905399 describes any process that modulates the frequency, rate or extent of apoptosis in activated CD4-positive, alpha-beta T cells.
• This regulatory process is essential for terminating immune responses and maintaining peripheral T cell homeostasis.
• Dysregulation contributes to persistent T cell accumulation in sarcoidosis and other inflammatory diseases.
• Key molecular players include TRAIL/Apo-2 ligand, IL-2 receptor signaling, and CD25.
• Experimental models range from knockout mice to CRISPR-engineered human T cell lines.
• Studying this term helps identify therapeutic targets for autoimmune diseases and T cell lymphomas.
Description
The Gene Ontology term GO:1905399, regulation of activated CD4-positive, alpha-beta T cell apoptotic process, defines any biological process that modulates the frequency, rate or extent of programmed cell death in activated CD4-positive, alpha-beta T cells. These cells are central to adaptive immunity, and their timely removal after an immune response is critical for preventing autoimmunity and chronic inflammation. The term encompasses both positive and negative regulation, integrating signals from cytokines, surface receptors, and intracellular checkpoints. Understanding this process is fundamental for immunology research, as defects in apoptosis regulation can lead to T cell accumulation, tissue damage, and disease. This article synthesizes published findings on the mechanisms, key genes, and experimental approaches used to study GO:1905399.
regulation of activated CD4-positive, alpha-beta T cell apoptotic process At A Glance
| GO ID | GO:1905399 |
|---|---|
| GO term | regulation of activated CD4-positive, alpha-beta T cell apoptotic process |
| Ontology | biological_process |
| Synonym | regulation of activated CD4-positive, alpha-beta T cell apoptosis |
| Major function | Modulates the frequency, rate or extent of apoptosis in activated CD4+ alpha-beta T cells |
| Related process | T cell homeostasis, immune response termination |
| Cellular context | Peripheral lymphoid organs, inflamed tissues |
| Key regulators | TRAIL/Apo-2 ligand, IL-2 receptor, CD25 |
What Is GO:1905399?
GO:1905399 is a biological process term that describes the regulation of apoptosis specifically in activated CD4-positive, alpha-beta T cells. It includes any molecular event that increases or decreases the initiation, execution, or resolution of apoptosis in these cells after they have been activated through their T cell receptor. The term is a child of broader apoptosis regulation terms and is distinct from regulation of apoptosis in naive or other T cell subsets.
Why Is regulation of activated CD4-positive, alpha-beta T cell apoptotic process Important in Cell Biology?
Regulation of activated CD4-positive, alpha-beta T cell apoptosis is critical for immune homeostasis and disease prevention. After an immune response, most activated CD4+ T cells must undergo apoptosis to prevent excessive inflammation and autoimmunity. Defects in this process can lead to persistent T cell accumulation, as seen in sarcoidosis where CD4+ T cell exhaustion reverses with clinical resolution. Conversely, excessive apoptosis can cause immunodeficiency. Understanding GO:1905399 provides insights into diseases such as autoimmune disorders, chronic infections, and T cell malignancies.
• Prevents autoimmunity by eliminating autoreactive activated CD4+ T cells.
• Controls the duration and intensity of immune responses.
• Dysregulation is linked to persistent inflammation in sarcoidosis.
• TRAIL/Apo-2 ligand expression on activated T cells mediates apoptosis.
• IL-2 receptor signaling regulates lymphoid homeostasis.
• CD4+CD25+ T cell development involves distinct regulatory mechanisms.
• Activation-mediated T cell unresponsiveness during Toxoplasma gondii infection involves apoptosis regulation.
• Human antigen-specific TCR alpha beta+ CD4-CD8- double-negative regulatory T cells modulate immune responses.
• T cells that regulate neutrophilic skin inflammation are characterized by specific phenotypes.
• Intestinal intraepithelial lymphocytes interact with epithelial cells in host defense.
What Happens During regulation of activated CD4-positive, alpha-beta T cell apoptotic process?
Activation-induced cell death (AICD) initiation
In simple terms: When T cells are repeatedly activated, they receive signals that can trigger their own death.
After activation, CD4+ alpha-beta T cells become susceptible to apoptosis through pathways such as AICD. This process is regulated by surface receptors including TRAIL/Apo-2 ligand, which is expressed on activated mouse T and B cells. The balance between survival and death signals determines whether the cell undergoes apoptosis.
Cytokine-dependent survival and death
In simple terms: Cytokines like IL-2 can either keep T cells alive or promote their death, depending on context.
IL-2 receptor signaling is a key regulator of lymphoid homeostasis. In vivo studies show that IL-2 receptor signals control the size and composition of T cell populations, partly by regulating apoptosis of activated CD4+ T cells. CD4+CD25+ T cell development is regulated by at least two distinct mechanisms, one of which involves apoptosis regulation.
Regulatory T cell influence
In simple terms: Some T cells suppress immune responses and can influence whether other T cells die.
Human antigen-specific TCR alpha beta+ CD4-CD8- double-negative regulatory T cells have been isolated and characterized; these cells can modulate immune responses and may affect apoptosis of activated CD4+ T cells. T cells that regulate neutrophilic skin inflammation also represent a regulatory subset with potential impact on T cell survival.
Infection and chronic stimulation
In simple terms: During infections, T cells may become unresponsive and undergo apoptosis as a control mechanism.
In acute Toxoplasma gondii infection in mice, activation-mediated CD4+ T cell unresponsiveness occurs, which involves regulation of apoptosis. In pulmonary sarcoidosis, local and systemic CD4+ T cell exhaustion reverses with clinical resolution, indicating that apoptosis regulation is linked to disease outcome.
Tissue-specific regulation
In simple terms: The environment where T cells reside, such as the gut, influences their survival.
Intestinal epithelial cells interact with intraepithelial lymphocytes in host defense, and this interaction can regulate T cell apoptosis. This highlights that GO:1905399 operates in diverse tissue contexts.
Key Genes Involved in GO:1905399 regulation of activated CD4-positive, alpha-beta T cell apoptotic process
The following genes and proteins have been experimentally linked to the regulation of activated CD4-positive, alpha-beta T cell apoptosis.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TRAIL (TNFSF10) | Induces apoptosis in activated T cells | Surface expression on activated T and B cells |
| IL2RA (CD25) | IL-2 receptor alpha chain; regulates survival | Controls lymphoid homeostasis |
| IL2RB | IL-2 receptor beta chain; signaling | Regulates T cell apoptosis |
| IL2RG | Common gamma chain; cytokine signaling | Affects T cell survival |
| FOXP3 | Regulatory T cell development | CD4+CD25+ T cell regulation |
| CD4 | Co-receptor for MHC class II | Defines T cell subset |
| CD8 | Co-receptor for MHC class I | Double-negative regulatory T cells |
| TCR alpha | Antigen recognition | TCR alpha beta+ cells |
| TCR beta | Antigen recognition | TCR alpha beta+ cells |
| BCL2 | Anti-apoptotic | Inferred from apoptosis regulation |
| BAX | Pro-apoptotic | Inferred from apoptosis regulation |
| CASP3 | Executioner caspase | Apoptosis execution |
| CASP8 | Initiator caspase | Death receptor pathway |
| FAS | Death receptor | AICD |
| FASLG | Death ligand | AICD |
| NFKB1 | Survival transcription factor | T cell survival |
| STAT5 | IL-2 signaling | Lymphoid homeostasis |
How Is regulation of activated CD4-positive, alpha-beta T cell apoptotic process Regulated?
The regulation of activated CD4-positive, alpha-beta T cell apoptosis is controlled by a network of cytokines, surface receptors, and intracellular signaling pathways. IL-2 receptor signaling is a central regulator, as shown by in vivo studies where disruption of IL-2 receptor signals alters lymphoid homeostasis. TRAIL/Apo-2 ligand expression on activated T cells provides an extrinsic death signal. Additionally, regulatory T cell subsets, such as CD4+CD25+ T cells and double-negative regulatory T cells, can modulate apoptosis through cell-cell contact or cytokine secretion. Infection and chronic stimulation can also shift the balance toward unresponsiveness and apoptosis.
regulation of activated CD4-positive, alpha-beta T cell apoptotic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TRAIL | Autoimmune inflammation | TRAIL knockout mice |
| IL2RA | Lymphoproliferation | IL2RA knockout mice |
| FOXP3 | IPEX syndrome | FOXP3 mutant mice |
| FAS | Autoimmune lymphoproliferative syndrome | FAS mutant mice |
| CD4 | HIV/AIDS | CD4 knockout mice |
Sarcoidosis and T cell exhaustion
In pulmonary sarcoidosis, local and systemic CD4+ T cell exhaustion is observed, and this exhaustion reverses with clinical resolution. This suggests that regulation of activated CD4+ T cell apoptosis is linked to disease persistence and resolution.
Autoimmune and inflammatory diseases
Defects in apoptosis regulation can lead to accumulation of activated CD4+ T cells, contributing to autoimmune and inflammatory conditions. For example, T cells that regulate neutrophilic skin inflammation are characterized in human skin, and their dysregulation may affect inflammation.
Infectious diseases
During acute Toxoplasma gondii infection, activation-mediated CD4+ T cell unresponsiveness occurs, which involves apoptosis regulation. This mechanism may help limit immunopathology but can also impair protective immunity.
Intestinal inflammation
The interaction between intestinal epithelial cells and intraepithelial lymphocytes is important for host defense, and dysregulation of apoptosis in these T cells may contribute to intestinal inflammation.
From regulation of activated CD4-positive, alpha-beta T cell apoptotic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate activated CD4+ T cell apoptosis? | CRISPR knockout in primary human T cells |
| Does a point mutation in gene Y alter apoptosis sensitivity? | CRISPR point mutation knock-in in Jurkat cells |
| Does overexpression of gene Z protect from apoptosis? | Lentiviral overexpression in mouse CD4+ T cells |
| Does a tagged protein localize to apoptotic machinery? | CRISPR knock-in of fluorescent tag |
| Does gene W affect T cell homeostasis in vivo? | Conditional knockout mouse |
| Does a regulatory element control gene expression? | CRISPR interference (CRISPRi) screening |
How to Study the regulation of activated CD4-positive, alpha-beta T cell apoptotic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Annexin V flow cytometry | Phosphatidylserine externalization | Quantify apoptosis |
| TUNEL assay | DNA fragmentation | Detect late apoptosis |
| Caspase activity assay | Caspase-3/7 activity | Measure apoptosis execution |
| Western blot | Protein expression/cleavage | Detect apoptosis regulators |
| ELISA | Cytokine levels | Measure IL-2, TRAIL |
| CRISPR knockout | Gene function | Test causality |
| RNA-seq | Transcriptome changes | Identify apoptosis pathways |
| Mouse infection model | In vivo T cell responses | Study unresponsiveness |
Flow cytometry-based apoptosis assays
Annexin V and propidium iodide staining followed by flow cytometry is commonly used to quantify apoptosis in activated CD4+ T cells. This method allows assessment of early and late apoptotic stages.
T cell activation and culture
In vitro activation of CD4+ T cells using anti-CD3/CD28 beads or mitogens, followed by cytokine treatment, is standard for studying apoptosis regulation. IL-2 is often added to maintain survival or induce AICD.
Genetic knockout and knockdown
CRISPR-Cas9 knockout or siRNA knockdown of candidate genes in T cell lines or primary cells helps determine their role in apoptosis regulation. This approach has been used to study IL-2 receptor signaling.
In vivo infection models
Mouse models of infection, such as Toxoplasma gondii, allow study of activation-mediated T cell unresponsiveness and apoptosis in a physiological context.
How CRISPR Can Be Used to Study GO:1905399 regulation of activated CD4-positive, alpha-beta T cell apoptotic process
Knockout
CRISPR knockout of candidate genes in primary CD4+ T cells or Jurkat cells can determine whether a gene is required for regulation of activated CD4+ T cell apoptosis. For example, knocking out IL2RA would test its role in survival signaling.
Point Mutation
Introducing specific point mutations in genes such as FAS or CASP8 can mimic human disease variants and reveal their impact on apoptosis sensitivity. This is useful for studying autoimmune lymphoproliferative syndrome.
Knock-in
Knock-in of fluorescent tags or reporter genes allows tracking of apoptosis regulators in live cells. For instance, tagging TRAIL with GFP can visualize its surface expression upon activation.
Overexpression
Overexpression of anti-apoptotic genes like BCL2 or pro-apoptotic genes like BAX can shift the balance of apoptosis in activated CD4+ T cells, helping to define their regulatory roles.
How EDITGENE Supports regulation of activated CD4-positive, alpha-beta T cell apoptotic process Research
Researchers studying regulation of activated CD4-positive, alpha-beta T cell apoptotic process-related genes often need to determine whether a candidate gene is causally involved in apoptosis regulation or simply correlated with it. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such causal studies in relevant T cell models.
Contact EDITGENE today to design your custom CRISPR model for regulation of activated CD4-positive, alpha-beta T cell apoptotic process research.
Frequently Asked Questions About regulation of activated CD4-positive, alpha-beta T cell apoptotic process
What is GO:1905399?
GO:1905399 is a Gene Ontology term for any process that modulates the frequency, rate or extent of apoptosis in activated CD4-positive, alpha-beta T cells.
What genes are involved in regulation of activated CD4-positive, alpha-beta T cell apoptotic process?
Key genes include TRAIL (TNFSF10), IL2RA (CD25), IL2RB, FOXP3, and FAS, among others.
Why is regulation of activated CD4+ T cell apoptosis important?
It prevents autoimmunity and chronic inflammation by eliminating excess activated T cells after an immune response.
How is activated CD4+ T cell apoptosis studied?
Common methods include flow cytometry with Annexin V, caspase assays, CRISPR knockout, and mouse infection models.
What diseases are linked to defects in this process?
Sarcoidosis, autoimmune lymphoproliferative syndrome, and inflammatory skin diseases have been associated with dysregulation.
What is the role of IL-2 in this process?
IL-2 receptor signaling regulates lymphoid homeostasis and can influence whether activated CD4+ T cells survive or undergo apoptosis.
Can CRISPR be used to study this GO term?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect gene function in this process.
What is activation-induced cell death (AICD)?
AICD is a form of apoptosis triggered by repeated T cell receptor stimulation, and it is a key mechanism in regulating activated CD4+ T cell numbers.
Which cytokines regulate activated CD4+ T cell apoptosis?
IL-2 is a major regulator, but other cytokines and TRAIL also play roles.
How does sarcoidosis relate to this process?
In sarcoidosis, CD4+ T cell exhaustion reverses with clinical resolution, suggesting apoptosis regulation is linked to disease outcome.
Conclusion
GO:1905399, regulation of activated CD4-positive, alpha-beta T cell apoptotic process, is a critical biological process for immune homeostasis. Its dysregulation contributes to autoimmune diseases, chronic infections, and inflammatory conditions. Key regulators such as TRAIL, IL-2 receptor, and FOXP3 have been identified through decades of research. Advances in CRISPR technology now allow precise interrogation of these pathways, offering new therapeutic opportunities. EDITGENE provides comprehensive CRISPR services to accelerate discovery in this field.
References
- 1. Hawkins C et al.. 2017. Local and Systemic CD4(+) T Cell Exhaustion Reverses with Clinical Resolution of Pulmonary Sarcoidosis.. J Immunol Res 2017:3642832 PMID: 29234685
- 2. Fischer K et al.. 2005. Isolation and characterization of human antigen-specific TCR alpha beta+ CD4(-)CD8- double-negative regulatory T cells.. Blood 105(7):2828-35 PMID: 15572590
- 3. Suto A et al.. 2002. CD4(+)CD25(+) T-cell development is regulated by at least 2 distinct mechanisms.. Blood 99(2):555-60 PMID: 11781238
- 4. Yoshikai Y. 1999. The interaction of intestinal epithelial cells and intraepithelial lymphocytes in host defense.. Immunol Res 20(3):219-35 PMID: 10741862
- 5. Mariani SM et al.. 1998. Surface expression of TRAIL/Apo-2 ligand in activated mouse T and B cells.. Eur J Immunol 28(5):1492-8 PMID: 9603453
- 6. Khan IA et al.. 1996. Activation-mediated CD4+ T cell unresponsiveness during acute Toxoplasma gondii infection in mice.. Int Immunol 8(6):887-96 PMID: 8671678
- 7. Leung DT et al.. 2000. Regulation of lymphoid homeostasis by IL-2 receptor signals in vivo.. J Immunol 164(7):3527-34 PMID: 10725707
- 8. Schaerli P et al.. 2004. Characterization of human T cells that regulate neutrophilic skin inflammation.. J Immunol 173(3):2151-8 PMID: 15265952
